Jack W. Love, D.Phil., M.D., CEO and Chief Scientific Officer, has over 30 years experience as a practicing cardiovascular and thoracic surgeon. Beginning in 1980, he worked on the concept and development of a stent-mounted autologous tissue replacement heart valve. He retired from surgical practice in 1989 to devote full time effort to the project, incorporated as Autogenics in 1990, to continue research and development, to conduct clinical trials in Europe, and to introduce the valve to the market. When these goals had been achieved, and $18 million of investment capital had been raised, a professional management team was installed in 1995. Dr. Love left the company at that time to explore new concepts for the treatment of valvular heart disease based on stentless reconstruction with autologous tissue. He is a named inventor or co-inventor on 20 patents related to medical devices.
Richard M. Love, VP for Operations has over 10 years experience in start-up medical device manufacturing and distribution, including 8 years of industry experience in the United Kingdom and Europe, 4 of which were with Autogenics, an autologous tissue replacement valve manufacturer. In addition to directing the implementation of a 4,000 square foot production, laboratory, and office facility, including a class 1,000 clean room, Mr. Love has established important contacts with key medical device distributors in the United Kingdom and other European countries. He also played an integral role in achieving certification of Autogenics’ Scotland facility to ISO 9001:EN46001 standards and the CE Mark for Autogenic’s heart valve product. He has obtained the CE Mark and ISO 9002 certification for CardioMend’s products and quality system, and is coordinating pre-production activities.
George F.C. Love, VP for Business and Legal Affairs, is an attorney with a background in business and regulatory law. He is admitted to the state bars in California and Missouri. While attending law school at the University of California, San Francisco (Hastings) he became familiar with start-up businesses and the heart valve industry as an early employee of Autogenics in the summer of 1990. Currently, Mr. Love is working part-time as Director of Legal Affairs for a privately held, St. Louis pharmaceutical company. He has been directing business administration, including business development, and legal and regulatory activities for CardioMend. He has obtained regulatory approval from the FDA for CardioMend's initial instruments as Class I (exempt) devices after a 510(k) submission.
Albert Duarte is a production and quality engineer with over 18 years of experience, including more than 9 years experience in the medical device industry. After graduating with a B.S. in Industrial Technology from Cal State Long Beach, Mr. Duarte spent 10 years working as a quality engineer for Hughes Aircraft Corporation. More recently he has worked with Circon Corporation and McGhan Medical, both medical device companies located in Santa Barbara, California, as a senior member of their respective Quality Engineering departments. Mr. Duarte has extensive experience working with ISO Standards and FDA Quality System Regulations, and he is very familiar with the process of taking a medical device product from the concept stage through to full commercialization. Mr. Duarte is employed with CardioMend as a Production Engineer. In addition to other responsibilities, he will manage the contract manufacturing activities that are performed on behalf of the company.
Larry Savage is a design engineer with over 25 years of experience in project management and consulting engineering, including more than 7 years designing and developing medical devices. He has substantial experience taking a variety of surgical and other medical devices from the concept stage through to commercialization. His experience includes work as Senior Project Engineer for AMSCO/HALL Surgical, Inc. of Santa Barbara, where he was responsible for the complete design, development and testing of several surgical instruments. He has also worked for Advanced Medical Systems in Minneapolis, where, among other things, he designed and developed measuring devices for use in lung surgery. Mr. Savage received a B.S. in mechanical engineering from the University of California, Santa Barbara (UCSB).
Currently, the Company is working with Mr. Robert Suggitt of McLean Engineering, Inc. in Vancouver, British Columbia. Mr. Suggitt has extensive experience in the design and development of medical devices. Most recently, before joining McLean Engineering, he served as Vice President of Research and Development for Autogenics, manufacturer of the first successful autologous tissue replacement heart valve. In addition, prior to working at Autogenics, Mr. Suggitt held various positions with Mitroflow International in Richmond, British Columbia, including that of Production Manager with responsibilities for all areas of production of Mitroflow’s bovine pericardial heart valve.
If you would like more information about CardioMend please contact us by email at firstname.lastname@example.org.